Recent advances in the treatment of childhood asthma: a clinical pharmacology perspective-Reference-Cited by-同舟云学术

Recent advances in the treatment of childhood asthma: a clinical pharmacology perspective

Published:2022-10-03 Issue:10 Volume:15 Page:1165-1176
ISSN:1751-2433
Container-title:Expert Review of Clinical Pharmacology
language:en
Short-container-title:Expert Review of Clinical Pharmacology

Author:

Alizadeh Bahmani Amir Hossein¹,Abdel-Aziz Mahmoud I.¹²,Maitland-van der Zee Anke H.¹³,Vijverberg Susanne J.H.¹³

Affiliation:

1. Amsterdam UMC Location University of Amsterdam, Department of Pulmonary Medicine, Amsterdam, The Netherlands

2. Department of Clinical Pharmacy, Faculty of Pharmacy, Assiut University, Assiut, Egypt

3. Amsterdam UMC Location University of Amsterdam, Department of Paediatric Pulmonology, Amsterdam, The Netherlands

Funder

Lung Foundation Netherlands

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17512433.2022.2131537

Reference122 articles.

1. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

2. Wirl C, Puklova V. Prevalence of asthma and allergies in children. WHO Fact Sheet. 2007. [cited 2022 Aug 5]. Available from: https://www.euro.who.int/__data/assets/pdf_file/0012/96996/3.1.pdf

3. Asthma phenotypes: the evolution from clinical to molecular approaches

4. Evidence That Severe Asthma Can Be Divided Pathologically into Two Inflammatory Subtypes with Distinct Physiologic and Clinical Characteristics

5. Toward clinically applicable biomarkers for asthma: An EAACI position paper

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Meta-analysis of the efficacy of montelukast sodium combined with nebulized inhalation in the treatment of childhood asthma;Minerva Surgery;2024-05

2. Developments in the Management of Severe Asthma in Children and Adolescents: Focus on Dupilumab and Tezepelumab;Pediatric Drugs;2023-09-02

3. Exhaled volatile organic compounds associated with risk factors for obstructive pulmonary diseases: a systematic review;ERJ Open Research;2023-06-08